益方生物-U
(688382)
| 流通市值：38.67亿 | | | 总市值：56.28亿 |
| 流通股本：3.96亿 | | | 总股本：5.77亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,837,074,642.19 | 1,919,444,422.57 | 2,012,228,106.17 | 1,526,456,432.88 |
| 应收票据及应收账款 | 183,932,192.72 | 176,565,554.92 | 77,600,000 | 77,600,000 |
| 应收账款 | 183,932,192.72 | 176,565,554.92 | 77,600,000 | 77,600,000 |
| 预付款项 | 9,212,716.37 | 20,462,712.69 | 19,313,934.87 | 16,588,481.49 |
| 其他应收款合计 | 9,598,575.9 | 6,648,253.09 | 4,373,884.82 | 4,103,980.06 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,039,818,127.18 | 2,123,120,943.27 | 2,113,515,925.86 | 2,129,648,894.43 |
| 非流动资产: | | | | |
| 固定资产 | 16,726,498.51 | 18,151,314.46 | 19,576,376.48 | 18,997,803.34 |
| 在建工程 | 1,347,264.15 | 500,000 | 2,630,188.64 | 3,389,579.29 |
| 使用权资产 | 9,775,685.2 | 11,729,920.89 | 16,964,489.5 | 19,174,176.42 |
| 无形资产 | 838,318.91 | 920,461.12 | 1,002,603.28 | 1,084,745.44 |
| 长期待摊费用 | 696,819.42 | 1,045,229.13 | 4,303,716.33 | 3,484,821.35 |
| 递延所得税资产 | 2,221,975.49 | 2,900,583.96 | - | - |
| 其他非流动资产 | 5,344,837.23 | 3,903,590.51 | 205,287.27 | 28,024,642.99 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 36,951,398.91 | 39,151,100.07 | 44,682,661.5 | 74,155,768.83 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,076,769,526.09 | 2,162,272,043.34 | 2,158,198,587.36 | 2,203,804,663.26 |
| 流动负债: | | | | |
| 短期借款 | - | - | 16,293,307.9 | - |
| 应付票据及应付账款 | 58,137,728.24 | 72,521,670.83 | 68,199,174.11 | 80,397,406.26 |
| 应付账款 | 58,137,728.24 | 72,521,670.83 | 68,199,174.11 | 80,397,406.26 |
| 合同负债 | 47,169,811.32 | 47,169,811.32 | - | - |
| 应付职工薪酬 | 20,918,464.98 | 25,369,209.37 | 27,188,989.82 | 21,470,194.55 |
| 应交税费 | 128,147.07 | 146,193.39 | 212,608.56 | 15,347.94 |
| 其他应付款合计 | 1,616,386.42 | 3,732,083.43 | 3,649,327.32 | 860,465.32 |
| 一年内到期的非流动负债 | 7,480,328.6 | 9,003,688.07 | 10,997,801.89 | 11,189,356.76 |
| 其他流动负债 | 657,083.71 | 331,612.01 | - | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 136,107,950.34 | 158,274,268.42 | 126,541,209.6 | 113,932,770.83 |
| 非流动负债: | | | | |
| 租赁负债 | 2,923,328.62 | 2,614,671.19 | 7,745,707.85 | 9,775,855.83 |
| 递延收益 | 880,000 | 880,000 | 880,000 | 880,000 |
| 递延所得税负债 | 2,221,975.49 | 2,900,583.96 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 6,025,304.11 | 6,395,255.15 | 8,625,707.85 | 10,655,855.83 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 142,133,254.45 | 164,669,523.57 | 135,166,917.45 | 124,588,626.66 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 576,658,841 | 575,000,000 | 575,000,000 | 575,000,000 |
| 资本公积 | 3,757,210,616.9 | 3,738,064,522.8 | 3,721,034,732.67 | 3,703,217,094.93 |
| 其他综合收益 | -11,333,684.47 | -10,740,168.32 | -10,994,615.41 | -10,505,109.6 |
| 未分配利润 | -2,387,899,501.79 | -2,304,721,834.71 | -2,262,008,447.35 | -2,188,495,948.73 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,934,636,271.64 | 1,997,602,519.77 | 2,023,031,669.91 | 2,079,216,036.6 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,934,636,271.64 | 1,997,602,519.77 | 2,023,031,669.91 | 2,079,216,036.6 |
| 负债和股东权益合计 | 2,076,769,526.09 | 2,162,272,043.34 | 2,158,198,587.36 | 2,203,804,663.26 |
| 公告日期 | 2024-04-30 | 2024-04-26 | 2023-10-28 | 2023-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |